Synthesis and anti-HIV-1 activity of 4-substituted-7-(2′-deoxy- 2′-fluoro-4′-azido-β-d-ribofuranosyl)pyrrolo[2,3-d]pyrimidine analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 22, 2011, Pages 6770-6772

  Guo, Xiaohe ^a   Li, Yujiang ^a   Tao, Le ^a   Wang, Qiang ^a   Wang, Shuyang ^b   Hu, Weidong ^b   Pan, Zhenliang ^b   Yang, Qinghua ^b   Cui, Yanmei ^b   Ge, Zhaopeng ^b   Dong, Lihong ^a   Yu, Xuejun ^a   An, Haoyun ^a   Song, Chuanjun ^b   Chang, Junbiao ^a,b  

^a Henan Academy of Science   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Anti HIV 1 activity; Pyrrolo 2,3 d pyrimidine; Ribonucleoside; Synthesis

Indexed keywords

4 AMINO 5 FLUORO 7 (2' DEOXY 2' FLUORO 4' AZIDO BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE; 4 AMINO 7 (2' DEOXY 2' FLUORO 4' AZIDO BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE; 4 HYDROXY 7 (2' DEOXY 2' FLUORO 4' AZIDO BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE; PYRROLO[2,3 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; VIRUS REPLICATION; WILD TYPE;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HUMANS; PYRIMIDINES; PYRROLES; RIBONUCLEOSIDES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80054728772     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.09.040     Document Type: Article

References (20)

1. S. Frank, and X. Peng J. Org. Chem. 71 2006 81
2. H. Kasai, Z. Oashi, F. Harada, S. Nishimura, N.J. Oppenheimer, P.F. Crain, J.G. Liehr, D.L. Von Minden, and J.A. McCloskey Biochemistry 14 1975 4198
3. R. Kazlauskas, P.T. Murphy, J.A. Wells, and D.D. Jamieson Aust. J. Chem. 36 1983 165
4. J.A. Montgomery, A.T. Shortnacy, D.A. Carson, and J.A. Secrist J. Med. Chem. 29 1986 2389
5. C.K. Chu, J. Matulic-Adamic, T. Huang, T.-C. Chou, J.H. Burchenal, J.J. Fox, and K.A. Watanabe Chem. Pharm. Bull. 37 1989 336
6. J.A. Montogomery, A.T. Shortnacy-Fowler, S.D. Clayton, J.M. Riordan, and J.A. Secrist J. Med. Chem. 35 1992 397
7. J.O. Ojwang, B.K. Bhattacharya, H.B. Marshall, B.E. Korba, G.R. Revankar, and R.F. Rando Antimicrob. Agents Chemother. 39 1995 2570
8. Chang, J.; Bao, X.; Wang, Q.; Guo, X.; Wang, W.; Qi X. Faming Zhuanli Shenqing Gongkai Shuomingshu, CN 101177442, 2008; Chem. Abstr. 2008, 149, 32518.
9. W. Hu, P. Wang, C. Song, Z. Pan, Q. Wang, X. Guo, X. Yu, Z. Shen, S. Wang, and J. Chang Bioorg. Med. Chem. Lett. 20 2010 7297 and references therein.
10. Summa, V.; Di Francesco, M. E.; Pompei, M. PCT Int. Appl. WO 084115, 2010; Chem. Abstr. 2010, 153, 250729.
11. D. McGee, and J. Martin Can. J. Chem. 64 1986 1885
12. M. Hans, M.R. Robert, J.M. Mary, C.R. Diane, P.H.V. Julien, and J.P. Ernest J. Med. Chem. 35 1992 1440
13. 4 requires 333.0724].
14. 3 requires 310.1064].
15. F. Seela, K. Xu, P. Chittepu, and X. Ming Nucleosides, Nucleotides Nucleic Acids 26 2007 607
16. F. Seela, K. Xu, and P. Chittepu Synthesis 2006 2005
17. F. Seela, P. Chittepu, Y. He, J. He, and K. Xu Nucleosides, Nucleotides Nucleic Acids 24 2005 847
18. 3 requires 328.0970].
19. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Cancer Res. 47 1987 936 942
20. Y. Cao, and Y. Guo ACTA Pharmaceutica Sinica 43 2008 253 258